Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Features +++ Essentials of Diagnosis ++ Dysphoric mood, mood lability, irritability, or depressed appearance, persisting for weeks to months at a time Characteristic neurovegetative signs and symptoms (eg, changes in sleep, appetite, concentration, and activity levels) Suicidal ideation, feeling of hopelessness +++ General Considerations ++ Clinical depression can be defined as a persistent state of unhappiness or misery that interferes with pleasure or productivity Incidence of depression in children Increases with age, from 1% to 3% before puberty to around 8% for adolescents Higher when other family members have been affected by depressive disorders Equal between sexes in childhood With the onset of puberty the rates of depression for females begin to exceed those for males by 5:1 Lifetime risk of depression ranges from 10% to 25% for women and 5% to 12% for men +++ Clinical Findings ++ Typically, a child or adolescent with depression begins to look unhappy and may make comments such as "I have no friends," "life is boring," "there is nothing I can do to make things better," or "I wish I were dead" Behavior patterns change from baseline and can include social isolation, deterioration in schoolwork, loss of interest in usual activities, anger, and irritability Sleep and appetite patterns commonly change Child may complain of tiredness and nonspecific pain such as headaches or stomach aches +++ Diagnosis ++ The American Academy of Pediatrics recommends annual screening for depression in children age 12 and older using a standardized measure Depression often coexists with other mental illnesses, such as ADHD Oppositional defiant disorder Conduct disorder Anxiety disorders Eating disorders Substance abuse disorders Depressed adolescents should also be screened for hypothyroidism and substance abuse +++ Treatment +++ Nonpharmacologic ++ Cognitive-behavioral therapy Improves depressive symptoms Focuses on building coping skills to change negative thought patterns Helps identify, label, and verbalize feelings and misperceptions +++ Pharmacologic ++ Fluoxetine (Prozac) Usual starting dose: 10 mg/d (60 mg max); recommend decrease maximum dosage by around one-third for prepubertal children Increase increment (after about 4 weeks): 10–20 mg; recommend using the lower dose increase increments for younger children FDA approved for depression in children: Yes (> age 8) Long half-life, no side effect from a missed dose Citalopram (Celexa) Usual starting dose:10 mg/d (40 mg max); recommend decrease maximum dosage by around one-third for prepubertal children Increase increment (after about 4 weeks):10–20 mg; recommend using the lower dose increase increments for younger children FDA approved for depression in children: No Few drug interactions Sertraline (Zoloft) Usual starting dose: 25 mg/d (200 mg max); recommend decrease maximum dosage by around one-third for prepubertal children Increase increment (after about 4 weeks):25–50 mg; recommend using the lower dose increase increments for younger children FDA approved for depression ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.